Lv3
368 积分 2025-01-10 加入
Low-dose rituximab as an adjuvant therapy in pemphigus
8个月前
已完结
Long-term effectiveness and safety of rituximab for the treatment of pemphigus
8个月前
已完结
Interleukin-2-secreting T helper cells promote extra-follicular B cell maturation via intrinsic regulation of a B cell mTOR-AKT-Blimp-1 axis
8个月前
已完结
Rituximab therapy for intractable pemphigus: A multicenter, open‐label, single‐arm, prospective study of 20 Japanese patients
8个月前
已完结
B‐cell targeted therapy of pemphigus
8个月前
已完结
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
8个月前
已完结
Pemphigus relapse: Mechanisms, risk factors, and agents associated with disease recurrence
8个月前
已完结
Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
8个月前
已完结
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
8个月前
已完结
The emergence of circulating activated autoreactive Dsg3-specific Tfr cells is associated with long-term efficacy of RTX in PV patients
8个月前
已完结
皖公网安备34019202002308
